5 results

  • ambrisentan

    (Ambrisentan)
    Exelan Pharmaceuticals, Inc.
    Ambrisentan tablets are indicated for treating pulmonary arterial hypertension (PAH) to improve exercise ability and delay clinical worsening, primarily in patients with WHO Functional Class II–III symptoms due to idiopathic, heritable PAH, or PAH associated with connective tissue diseases.

  • amlodipine besylate

    (Amlodipine besylate)
    Exelan Pharmaceuticals, Inc.
    Amlodipine besylate is indicated for treating hypertension to lower blood pressure and reduce cardiovascular event risks. It is also used for treating chronic stable angina, vasospastic angina, and in patients with documented coronary artery disease to reduce hospitalization and revascularization procedure risks.

  • calcium acetate

    (Calcium Acetate)
    EXELAN PHARMACEUTICALS, INC.
    Calcium acetate is indicated as a phosphate binder to reduce serum phosphorus levels in patients with end-stage renal disease (ESRD).

  • dofetilide

    (Dofetilide)
    EXELAN PHARMACEUTICALS, INC.
    Dofetilide capsules are indicated for maintaining normal sinus rhythm and delaying the recurrence of atrial fibrillation/atrial flutter in symptomatic patients after conversion. They are also used for converting atrial fibrillation/flutter to normal sinus rhythm, though not effective for paroxysmal atrial fibrillation.

  • lidocaine

    (LIDOCAINE)
    EXELAN PHARMACEUTICALS, INC.